<p>KK mice were administrated urantide (30 µg/kg/day) for 14 days prior to calculation of glucose loading (A) and area under the curve (AUC) of changes in blood glucose levels (B). Control: C57BL/6J mice were treated with saline for 14 days; Urantide: C57BL/6J mice were treated with urantide for 14 days; KK:KK mice were treated with saline for 14 days; KK+Urantide: KK mice were treated with urantide for 14 days. Each value is mean±SD (n=6-8 for each group, *<i>P</i><0.05 vs control; <sup># </sup><i>P</i><0.05 vs KK group).</p
<p>(A) Variation and (B) area under the glycemia curve at 0, 30, 60, and 180 min for mice treated wi...
<p>(A) Intraperitoneal glucose tolerance test (ipGTT) in males after 16 wk of HFD. (B) Respective ar...
<p>(<b>A</b>) RBG was examined weekly during ZBPYR administration. ZBPYR significantly reduced gluco...
<p>(<b>A</b>) Serum uric acid levels of mice were significantly increased after daily injection of u...
<p>The indicated doses of novel compounds (codes and chemical structures shown above the bar graphs)...
<p>KK mice were administrated urantide (30 µg/kg/day) for 14 days prior to western blot analysis wit...
<p>KK mice were administrated urantide (30 µg/kg/day) for 14 days prior to measurement of (<b>A</b>)...
<p>An OGTT (3 g/kg) was performed after drug administration for 14 days. (a) Blood glucose in TAC tr...
<p>Mice were provided ad libitum access to high fat diet (HFD) lacking or containing 0.14% ursolic a...
<p>(<b>A</b>) Blood glucose levels of physiological saline- and 6×mGLP-1-treated mice over a 120-min...
<p>(A) Blood glucose levels were measured in overnight-fasted female <i>db/db</i> mice (n = 9–10 per...
<p>Overnight-fasted C57BL/6 mice were orally dosed with vehicle (white circles), sitagliptin (sita) ...
<p>A and C showed results of OGTT in each group at the fifth and the tenth week. B and D showed area...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>(A) Blood glucose levels in vehicle- and empagliflozin-treated (3mg/kg for 8 days) mice during an...
<p>(A) Variation and (B) area under the glycemia curve at 0, 30, 60, and 180 min for mice treated wi...
<p>(A) Intraperitoneal glucose tolerance test (ipGTT) in males after 16 wk of HFD. (B) Respective ar...
<p>(<b>A</b>) RBG was examined weekly during ZBPYR administration. ZBPYR significantly reduced gluco...
<p>(<b>A</b>) Serum uric acid levels of mice were significantly increased after daily injection of u...
<p>The indicated doses of novel compounds (codes and chemical structures shown above the bar graphs)...
<p>KK mice were administrated urantide (30 µg/kg/day) for 14 days prior to western blot analysis wit...
<p>KK mice were administrated urantide (30 µg/kg/day) for 14 days prior to measurement of (<b>A</b>)...
<p>An OGTT (3 g/kg) was performed after drug administration for 14 days. (a) Blood glucose in TAC tr...
<p>Mice were provided ad libitum access to high fat diet (HFD) lacking or containing 0.14% ursolic a...
<p>(<b>A</b>) Blood glucose levels of physiological saline- and 6×mGLP-1-treated mice over a 120-min...
<p>(A) Blood glucose levels were measured in overnight-fasted female <i>db/db</i> mice (n = 9–10 per...
<p>Overnight-fasted C57BL/6 mice were orally dosed with vehicle (white circles), sitagliptin (sita) ...
<p>A and C showed results of OGTT in each group at the fifth and the tenth week. B and D showed area...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>(A) Blood glucose levels in vehicle- and empagliflozin-treated (3mg/kg for 8 days) mice during an...
<p>(A) Variation and (B) area under the glycemia curve at 0, 30, 60, and 180 min for mice treated wi...
<p>(A) Intraperitoneal glucose tolerance test (ipGTT) in males after 16 wk of HFD. (B) Respective ar...
<p>(<b>A</b>) RBG was examined weekly during ZBPYR administration. ZBPYR significantly reduced gluco...